This is a randomized, multi-center and partially blinded trial of six regimens of the soft gelatin capsule of saquinavir (SQVSGC) in combination with ritonavir or nelfinavir and combinations of delavirdine, and/or adefovir dipivoxil. The treatments will be for 24 weeks approximately. Study subjects are HIV infected with prior indinavir use and with HIV-1 RNA >or = 2,000 and
Showing the most recent 10 out of 767 publications